SNHG12 and atherosclerosis: Dysregulation of the lncRNA Snhg12 is involved in a variety of pathogeneses, such as those of LDL-induced endothelial cell injury in atherosclerosis (Mao et al., 2021) and endometrial (Cai et al., 2021), gastric (Zhang T. et al., 2021), and hepatocellular cancer (Zhang Q. et al., 2021).